knowledge -WSS

knowledge

author：knowledge 2025-09-29 16:35:28 - browse：5

Steven Pearson — ICER President Steven D. Pearson Craig F. Walker/The Boston Globe

Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. But a meeting Thursday at the Massachusetts Institute of Technology may prove to be the exception to that rule.

Patients Rising Now, an advocacy group that says it promotes transparency in health care and that is a fierce opponent of ICER’s, is expected to face off with the self-professed “watchdog of drug pricing” as it reviews three drugs for Duchenne muscular dystrophy.

Dozens of Duchenne patients and their families — many of whom also express concern that ICER’s review could undermine insurers’ already tepid interest in the treatments — are also expected to be in attendance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Asbestos, a deadly carcinogen, banned by EPA

WSS

The CDC's new social media misinformation war

Updated Covid vaccine has 54% effectiveness, new study suggests

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Colonoscopy prep: Liquid

Readout LOUD: Venture capital, Gilead, and more M&A

Wikipedia

knowledge

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Readout LOUD: Venture capital, Gilead, and more M&A

Activists slam private health insurers over coverage restrictions

Stop the failed accountable care organization experiment

New air purifier tech could be key to improving indoor air quality

Unique patient identifier: Experts argue the benefits, pitfalls

New air purifier tech could be key to improving indoor air quality

Baby aspirin cuts fat buildup in liver disease patients, in small study

Trump demands the U.S. pay no more for drugs than other countries … again

Physicians and social media: If you see something, say something?

focus

Physicians and social media: If you see something, say something?

Health AI adoption puts security, privacy startups on investors' radar

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Neuroscience’s long legacy of racism

Gene therapy for Afghan refugees’ infant will be fully covered

Global cancer cases to surge 77% by 2050, WHO report says

Wikipedia

focus

Wikipedia

focus